Key result
Mitral valve repair for infective endocarditis provides better outcomes than replacement, though this superiority is largely driven by cohort studies from highly experienced centers.
Why the study?
Does mitral valve repair improve early and late survival compared to mitral valve replacement in patients with infective endocarditis?
Does mitral valve repair improve early and late survival compared to mitral valve replacement in patients with infective endocarditis?
Answers are grounded in this paper and cite their sources.
The decision to repair or replace a mitral valve in infective endocarditis should be individualized based on tissue damage and surgical expertise through a multidisciplinary EndoTeam.
The meta-analysis by He et al. has the worth to cover, as much as possible, a gap of scientific evidence were conducting a randomized trial appears very complex for ethical and logistical reasons. The authors concluded that mitral valve repair (MVP) provides better-pooled results, both early and late, with respect to mitral valve replacement. However, the superiority of MVP is driven by some single large cohort studies where surgeons had wide experience in the field of MVP for infective endocarditis. This finding is also confirmed by other studies. But if mitral repair produces such a better short- and long-term survival than replacement, why are there no clear indications from consensus and guidelines pushing surgeons toward the pursuit of a reconstructive procedure at almost any cost? We wonder to repair or not to repair, is that really the question? The AATS consensus suggests repairing "whenever possible" but without providing more specific indications. If the two primary goals of surgery are total removal of infected tissues and reconstruction of cardiac morphology, including repair or replacement of the affected valve(s), probably MVP should be performed in case of less extensive tissue detriment by the infection. In more wide valve involvement, MVP may be the choice but only in very expert hands and in Centers with a very large volumes of valve repairing. This decision cannot, therefore, be the result of the choice of an individual but must derive from a careful multidisciplinary discussion to be held in an EndoTeam.
No takes yet. Share an insight, caveat, or question.
Mauro et al. (2022) conducted an editorial in Infective endocarditis. Mitral valve repair vs. Mitral valve replacement was evaluated. Mitral valve repair for infective endocarditis provides better outcomes than replacement, though this superiority is largely driven by cohort studies from highly experienced centers.
Synapse has enriched 10 related papers. Consider them for comparative context: